MRPL22

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MRPL22 mutation is significantly associated with the immune_cell of many other genes, with 2 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MRPL22-associated genes across cancer lineages are CD8+ Tem and Macrophages M2. Each is linked with MRPL22 in more than 1 cancer types. Because this analysis shows association rather than direction, both MRPL22-to-partner and partner-to-MRPL22 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CD8+ Tem grouped by MRPL22-low versus MRPL22-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MRPL22→partner) and Y-score (partner→MRPL22) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECCD8+ Tem →+0.005+5.258<.001.02931
UCECMacrophages M2 →+0.017+2.925.008.03111
Each partner links to its Q-omics profile. Showing the 2 strongest of 2 associations by consensus.

CD8+ Tem by MRPL22 expression — UCEC

Box plot of CD8+ Tem in MRPL22-low vs MRPL22-high samples in UCEC.

Explore this box plot interactively →

Exploration